Tenon Medical, Inc. - Common Stock (TNON)

LOS GATOS, CA / ACCESS Newswire / October 29, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients with sacro-pelvic disorders, today announced plans to release financial results for the third quarter ended September 30, 2026 after market close on Thursday, November 12, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.

~ New decortication system is the latest advancement in Tenon's next-generation SI joint fusion platform with additional innovative product launches expected in the coming quarters ~~ Quickstep Decorticator designed to streamline joint decortication and simplify the SImmetry+ surgical workflow ~~ Full market release of Quickstep targeted for the first quarter of 2027. Company believes Quickstep will further support long-term adoption of the SImmetry+ System ~

~Newly issued patents continue to solidify the company's position as an innovator in the rapidly growing sacro-pelvic fusion market~~Portfolio now includes 38 issued U.S. patents and 9 international patents, with 31 applications pending~~Company anticipates continued additions to its IP portfolio along with several product launches in the coming quarters~

~ SImmetry+ System generated approximately $1.2 million in incremental revenue during limited launch period ~~ Company plans to support anticipated demand for the SImmetry+ System by expanding its instrument set inventory as needed ~~ New SImmetry+ 3D printed screw is the first component of a next-generation lateral SI joint fusion system, and the first of several Company product launches expected in the coming quarters ~

LOS GATOS, CA / ACCESS Newswire / September 14, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, announced today it has closed its previously announced warrant inducement agreement with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's shares of common stock (the "Existing Warrants").

LOS GATOS, CA / ACCESS Newswire / September 11, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders announced today it has entered into warrant exercise agreements with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's shares of common stock (the "Existing Warrants"). In consideration for the immediate exercise in full of the Existing Warrants for gross cash proceeds of $2,872,338.58, the exercising holders will receive in a private placement new unregistered warrants (the "New Warrants") to purchase up to an aggregate of 858,269 shares of common stock (equal to 150% of the shares of common stock issued in connection with the exercise of the Existing Warrants) with an exercise price of $5.02 per share. The New Warrants are immediately exercisable on the date of issuance and will expire five years from the date of issuance.

Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) shares increased by 110.6% to $1.39 during Friday's regular session. Tenon Medical (NASDAQ:TNON) shares rose 69.71% to $8.99. The company's market cap stands at

Gainers Tenon Medical (NASDAQ:TNON) shares moved upwards by 49.2% to $7.91 during Friday's pre-market session. The company's market cap stands at $3.5 million. Biodexa Pharmaceuticals (NASDAQ:BDRX) stock rose

Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 76.4% to $4.3 during Thursday's regular session. The market value of their outstanding shares is at $1.6 million. AEON Biopharma (AMEX:AEON) shares

Sept. 10, 2026 Peraso Inc. (NASDAQ: PRSO) is positioning its 60GHz millimeter-wave (mmWave) technology at the intersection of military autonomy, stealth communications, UAVs and Edge AI as the U.S. military accelerates the transition of autonomous systems from testing toward operational deployment.

Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 48.8% to $3.63 during Thursday's pre-market session. The market value of their outstanding shares is at $1.6 million. AEON Biopharma (AMEX:AEON) stock

~ Company Takes Proactive Step to Strengthen Balance Sheet and Maintain Flexibility to Execute on Continued Business Momentum ~